← All indications
Blepharitis
Inflammation of the eyelids.
Subtype terms (1)
More specific conditions that are subtypes of Blepharitis in the MeSH hierarchy.
Drugs by status
Approved for this indication (4)
Phase 4 trials (14)
Phase 3 trials (10)
Phase 2 trials (5)
Organizations
Organization Involved with Phase 4 Indications (11)
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (15)
- Galderma
- Inspire Pharmaceuticals
- Kala Pharmaceuticals, Inc.
- Laboratoires Thea
- NicOx
- Virginia Eye Consultants
- Tauber Eye Center
- Sall Research Medical Center
- Wolstan & Goldberg Eye Associates
- Isfahan University
- University of Alabama, Birmingham
- Abrams Eye Center, Cleveland, OH
- South Shore Eye Care
- Keyrus Biopharma
- AxeroVision, Inc.
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (3)